Naoki Wada, MD

Disclosure information not submitted.

Presentation(s):

• LBA01-18: Comparison of Mirabegron and Vibegron for Clinical Efficacy and Safety in Female Patients with Overactive Bladder: a Multicenter, Prospective Randomized Crossover Trial

  Sunday, April 30, 2023
  7:00 AM – 9:00 AM CST